Genezen’s new viral vector process development lab

Scroll Down

Our new state-of-the-art, cGMP-compliant multi-vector production facility is now open!

Our deep expertise in development and manufacture of viral vectors coupled with this new facility and equipment will accelerate our partners’ abilities to advance life-saving therapies into the clinic.

The lab will deliver a full suite of process development capabilities to support cGMP and commercial readiness, upstream and downstream process improvements, research grade and preclinical vector production, and analytical assay development and validation from the site.

You may also be interested in...

Our Capabilities

Genezen offers contract process development, GMP viral vector production, transduced cell...

Read more

Operations commence at Genezen’s lenti- and…

Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing...

Read more

Genezen Appoints Vice President of Quality…

Genezen Inc., a cell and gene therapy Contract Development and Manufacturing...

Read more

Suspension platform development for lentiviral vector…

Development of a Transfection-based, Scalable, Serum-Free, Single-Use Suspension Platform for Manufacturing...

Read more